Stock info Gilead Sciences
Stock info Gilead Sciences
Stock: Gilead Sciences (US Tech), ISIN: US3755581036
| Last Price | 68.29 | Max Price | 71.73 |
| Min Price | 56.65 | 1 Year return | 5.09 |
| Avg. Target | 73.40 | Expected Return | 7.48 % |
| Sector | Health Care | Subsector | Biotechnology |
| Sell | 0 | Rating |
 
|
| Hold | 3 | Concensus |
 
|
| Buy | 2 | ||
| Annual report 2016 |
Gilead Sciences, Inc. is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. Gilead Sciences' mission is to advance the care of patients suffering from life-threatening diseases worldwide. In addition to Gilead Sciences' marketed products, Gilead Sciences has a clinical, preclinical and research pipeline focused on developing anti-infectives. Gilead Sciences’ stocks are traded in New York and the company is a component of the NASDAQ 100-index (ISIN: US3755581036/ Symbol: GILD).
Contact info:Street: Foster City, CA 94404Zip Code: CA 94404City: Foster CityCountry: USAPhone: (650) 5743000Email: investor_relations@gilead.comWebsite: www.gilead.comCEO: John C. MartinCFO: Robin L. Washington
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContact |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
©2021 ValueSpectrum. All Rights Reserved
Developed and maintained by 